Prevention and treatment of cytomegalovirus disease in heart transplant patients
- 1 August 2000
- journal article
- review article
- Published by Elsevier
- Vol. 19 (8) , 731-735
- https://doi.org/10.1016/s1053-2498(00)00096-6
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Infection in Organ-Transplant RecipientsNew England Journal of Medicine, 1998
- PREEMPTIVE TREATMENT FOR THE PREVENTION OF CYTOMEGALOVIRUS DISEASETransplantation, 1998
- Prevention and treatment of cytomegalovirus infection and disease in heart transplant recipientsCurrent Opinion in Cardiology, 1998
- CYTOMEGALOVIRUS PROPHYLAXIS WITH ANTIVIRAL AGENTS IN SOLID ORGAN TRANSPLANTATIONTransplantation, 1998
- GanciclovirDrugs, 1998
- CORRELATION OF CYTOMEGALOVIRUS DNA LEVELS WITH RESPONSE TO ANTIVIRAL THERAPY IN CARDIAC AND RENAL ALLOGRAFT RECIPIENTS1Transplantation, 1997
- Prophylaxis against CMV infection in transplant patientsJournal of Antimicrobial Chemotherapy, 1997
- Preemptive Ganciclovir Therapy To Prevent Cytomegalovirus Disease in Cytomegalovirus Antibody-Positive Renal Transplant RecipientsAnnals of Internal Medicine, 1995
- SYMPTOMATIC CYTOMEGALOVIRUS DISEASE IN THE CYTOMEGALOVIRUS ANTIBODY SEROPOSITIVE RENAL TRANSPLANT RECIPIENT TREATED WITH OKT31,2Transplantation, 1992
- Combined antibody and ganciclovir treatment of murine cytomegalovirus-infected normal and immunosuppressed BALB/c miceAntimicrobial Agents and Chemotherapy, 1989